Literature DB >> 32416593

Development of a RP-HPLC method for simultaneous determination of reference markers used for in-situ rat intestinal permeability studies.

Murat Soyseven1, Mustafa S Kaynak2, Mustafa Çelebier3, Hassan Y Aboul-Enein4, Göksel Arli5.   

Abstract

One of the most common techniques for assessing the intestinal absorption characteristics of drugs is single-pass intestinal perfusion (SPIP) method. Metoprolol tartrate (MT, reference standard) and phenol red (PR, zero permeability marker) are the compounds that are normally used in SPIP studies. The aim of this study was to develop a reverse phase high-performance liquid chromatography (RP-HPLC) method combined with UV-detection for the simultaneous determination of MT and PR in the perfusion medium used in SPIP experiments. Elution was performed using a Restek Raptor C18 column (5 μm, 4.6 mm × 250) at a temperature of 25 °C. The mixture of the mobile phase consisted of (MeOH):(Phosphate buffer solution, PBS), (20 mM, pH 3.0 adjusted with ortho-phosphoric acid),(55:45, v/v). Flow rate and column temperature were set at 1.2 mL min-1 and 25 °C, respectively. MT and PR were injected as 20 µL into the HPLC system. UV detection was performed at 227 nm. The obtained retention times were reported as 2.89 and 3.80 min for MT and PR, respectively. The developed RP-HPLC method was validated according to Q2(R1) guideline of The International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH). The method was linear within the range of 2-50 μg mL-1 for PR and 10-75 μg mL-1 for MT. The developed RP-HPLC method was successfully applied on determination of MT and PR in perfusion medium. The developed method could be helpful for researchers working on in-situ rat intestinal permeability studies and it could be easily modified on further studies.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  HPLC; Metoprolol tartrate; Oral absorption; Permeability; Phenol red

Mesh:

Substances:

Year:  2020        PMID: 32416593     DOI: 10.1016/j.jchromb.2020.122150

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  1 in total

1.  A stability indicating RP-HPLC method for determination of the COVID-19 drug molnupiravir applied using nanoformulations in permeability studies.

Authors:  Tuba Reçber; Selin Seda Timur; Sevilay Erdoğan Kablan; Fatma Yalçın; Tutku Ceren Karabulut; R Neslihan Gürsoy; Hakan Eroğlu; Sedef Kır; Emirhan Nemutlu
Journal:  J Pharm Biomed Anal       Date:  2022-02-26       Impact factor: 3.571

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.